loading

Tscan Therapeutics Inc (TCRX) 最新ニュース

pulisher
Nov 28, 2025

How TScan Therapeutics Inc. stock reacts to oil pricesJuly 2025 Reactions & Community Driven Trade Alerts - moha.gov.vn

Nov 28, 2025
pulisher
Nov 28, 2025

Is TScan Therapeutics Inc a good long term investmentStock Liquidity Analysis & Free Tools to Find Winning Stocks - earlytimes.in

Nov 28, 2025
pulisher
Nov 27, 2025

Is TScan Therapeutics Inc. stock dividend yield sustainableTrade Exit Report & Daily Technical Stock Forecast Reports - moha.gov.vn

Nov 27, 2025
pulisher
Nov 26, 2025

TScan Therapeutics Approves Key Employee Retention Program - TipRanks

Nov 26, 2025
pulisher
Nov 26, 2025

[8-K] TScan Therapeutics, Inc. Reports Material Event | TCRX SEC FilingForm 8-K - Stock Titan

Nov 26, 2025
pulisher
Nov 24, 2025

Cluey Ltd Launches $4.5 Million Entitlement Offer - The Globe and Mail

Nov 24, 2025
pulisher
Nov 24, 2025

Tscan Therapeutics Inc (TCRX) is looking forward to a strong quarter - Setenews

Nov 24, 2025
pulisher
Nov 21, 2025

Reversal indicators forming on TScan Therapeutics Inc. stockProfit Target & Consistent Profit Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is TScan Therapeutics Inc. stock positioned well for digital economyTrade Ideas & Daily Oversold Bounce Ideas - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Applying chart zones and confluence areas to TScan Therapeutics Inc.2025 Pullback Review & Reliable Price Breakout Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is TScan Therapeutics Inc. building a consolidation baseJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

How TScan Therapeutics Inc. stock performs in high volatility markets2025 Market Outlook & Expert Curated Trade Setups - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

TScan Therapeutics (NASDAQ:TCRX) Cut to Equal Weight at Morgan Stanley - Defense World

Nov 17, 2025
pulisher
Nov 17, 2025

Equities Analysts Issue Forecasts for TCRX FY2025 Earnings - Defense World

Nov 17, 2025
pulisher
Nov 16, 2025

Best data tools to analyze TScan Therapeutics Inc. stockJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

How TScan Therapeutics Inc. stock reacts to global recession fears2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

HC Wainwright Cuts TScan Therapeutics (NASDAQ:TCRX) Price Target to $7.00 - Defense World

Nov 16, 2025
pulisher
Nov 15, 2025

Should you wait for a breakout in TScan Therapeutics Inc.Weekly Risk Summary & Scalable Portfolio Growth Methods - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

How TScan Therapeutics Inc. stock performs in rate cut cyclesWeekly Trade Review & Real-Time Stock Movement Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Using data filters to optimize entry into TScan Therapeutics Inc.2025 Earnings Impact & Technical Pattern Recognition Alerts - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Morgan Stanley Downgrades TScan Therapeutics to Equalweight From Overweight - MarketScreener

Nov 14, 2025
pulisher
Nov 13, 2025

Morgan Stanley downgrades Tscan Therapeutics stock on delayed trials By Investing.com - Investing.com Canada

Nov 13, 2025
pulisher
Nov 13, 2025

Morgan Stanley downgrades Tscan Therapeutics stock on delayed trials - Investing.com India

Nov 13, 2025
pulisher
Nov 13, 2025

HC Wainwright & Co. Maintains TScan Therapeutics (TCRX) Buy Recommendation - Nasdaq

Nov 13, 2025
pulisher
Nov 13, 2025

Is TScan Therapeutics Inc. still worth holding after the dipQuarterly Investment Review & Weekly Breakout Stock Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Technical signs of recovery in TScan Therapeutics Inc.Weekly Market Outlook & Accurate Technical Buy Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

TScan Therapeutics Draws Analyst Optimism Despite Growing Losses - Finimize

Nov 13, 2025
pulisher
Nov 13, 2025

Applying sector rotation models to TScan Therapeutics Inc.Quarterly Portfolio Summary & Low Volatility Stock Recommendations - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

TScan Therapeutics Reports Increased Revenue Amid Rising Losses - The Globe and Mail

Nov 13, 2025
pulisher
Nov 13, 2025

TScan Therapeutics, Inc. (TCRX) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com

Nov 13, 2025
pulisher
Nov 12, 2025

Published on: 2025-11-12 17:29:17 - newser.com

Nov 12, 2025
pulisher
Nov 12, 2025

Tscan Therapeutics earnings beat by $0.06, revenue topped estimates - Investing.com Canada

Nov 12, 2025
pulisher
Nov 12, 2025

What technical models suggest about TScan Therapeutics Inc.’s comebackWeekly Investment Report & Community Trade Idea Sharing - newser.com

Nov 12, 2025
pulisher
Nov 12, 2025

TScan Therapeutics, Inc. Q3 Loss Increases, But Beats Estimates - Nasdaq

Nov 12, 2025
pulisher
Nov 12, 2025

TScan Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 12, 2025
pulisher
Nov 12, 2025

TScan Therapeutics Q3 revenue jumps - MarketScreener

Nov 12, 2025
pulisher
Nov 12, 2025

TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

Nov 12, 2025
pulisher
Nov 12, 2025

TScan (NASDAQ: TCRX) secures FDA agreement on TSC-101 pivotal design; runway to 2027 - Stock Titan

Nov 12, 2025
$40.02
price up icon 0.45%
$104.46
price down icon 1.13%
$32.36
price up icon 1.38%
$103.15
price up icon 0.44%
biotechnology ONC
$340.61
price down icon 0.01%
$207.77
price up icon 1.59%
大文字化:     |  ボリューム (24 時間):